QLI (Qilian International Holding Group Limited) Gross Margin

Official company branding of Qilian International Holding Group Limited (QLI)

Stable demand for Chinese raw materials minimizes volatility, as confirmed by the gross margin ratio. Confidence in Qilian International (QLI) is based on a synthesis of traditional and modern production methods. The company's innovative development vector makes Qilian International (QLI) a defensive asset. The value of 1.30 represents the current metric, demonstrating effective cost management and the resilience of the business's operating cash flow.

QLI - qlsyy.net Return on Gross Profit over the range 07/04/2022 - 08/17/2024

Analytical breakdowns and data insights for company Qilian International Holding (QLI)

Summary company analysis:Qilian International Holding - QLI
Mass-produced product of qlsyy.net

This indicator is calculated as the ratio of the difference between revenue and direct production costs to total sales. It determines the efficiency of cost-of-goods-sold management and the business's ability to generate profit before accounting for operating expenses. For Qilian International (QLI), amid price wars and regulatory pressure, the annual gross margin reflects the business's critical resilience against the expansion of the public sector.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Theravance Biopharma - Return on Gross Profit|Gross Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Return on Gross Profit|Gross Profit Margin Tectonic Therapeutic|TNXP: Gross Margin|SXT China (SXTC) - Gross Margin|Gross Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Return on Sales by Gross Profit|Gross Profitability Invizyne (EXOZ)|ORMP - Gross Profit Margin|Gross Margin ENTX (Entera Bio)|Gross Sales Margin MindWalk Therapeutics|ABVC: Return on Gross Profit|CPIX - Gross Margin|QNTM (Quantum BioPharma) - Return on Gross Profit|Gross Profitability Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Gross Margin|Gross Margin ranitherapeutics.com|Gross Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Gross Return on Sales|lexariabioscience.com - Return on Gross Profit|Gross Margin Pulmatrix Inc PULM|Pheton Holdings - Gross Margin|Gross Profitability Margin APM|Lyra Therapeutics, Inc. (LYRA) - Gross Profitability|Gross Profit Margin Impact BioMedical, Inc. (IBO)|Gross Profitability TNF Pharma|YCBD: Gross Profit Rate|Gross Margin PRFX|CYTO - Gross Profit Margin|Gross Profitability Lipella LIPO|Gross Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Gross Profitability|Procaps (PROC) - Return on Gross Profit|PTPI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin